AnaptysBio, Inc. (NASDAQ: ANAB) reported Q4 EPS of $1.58, $0.71 better than the analyst estimate of $0.87. Revenue for the quarter came in at $108.25 million versus the consensus estimate of $87.09 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.